Holding(s) in Company

RNS Number : 0712S

Proteome Sciences PLC

16 December 2016

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii				PROTEOME SCIENCES PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights					YES
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii		VULPES LIFE SCIENCES FUND
4. Full name of shareholder(s)  (if different from 3.):iv
5. Date of the transaction and date on which the threshold is crossed or reached: v		14 DECEMBER 2016
6. Date on which issuer notified:		15 DECEMBER 2016
7. Threshold(s) that is/are crossed or reached: vi, vii		18%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0003104196

36,573,125

36,573,125

52,973,125

52,973,125

18.00%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

52,973,125

18.00%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:	[e-mail]
14. Contact name:	Victoria Birse
15. Contact telephone number:

Note: Annex should only be submitted to the FCA not the issuer
Annex: Notification of major interests in share
A: Identity of the persons or legal entity subject to the notification obligation
Full name (including legal form of legal entities)	VULPES LIFE SCIENCES FUND
Contact address (registered office for legal entities)	c/o Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands
Phone number & email
Other useful information (at least legal representative for legal persons)
B: Identity of the notifier, if applicable
Full name	Stephen Diggle
Contact address	One George Street #07-03 Singapore 049145
Phone number & email	Tel:  [phone] (Main) Email: [e-mail]
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)	Director
C: Additional information
Email address: Complete the required TR-1 form and email it to: Major shareholdings [e-mail] Fax number: You can print the TR-1 form, complete it and fax it to: 020 7066 0050
For notes on how to complete form TR-1 please see the FCA website.

 

END

 

 

HOLGGGAPPUPQUBQ